Showing results (671-680 of 705) with videos related to

Sort By:
Pageof 71
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2022
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)Heidi S Donovan, Susan M Sereika, Lari B Wenzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2012
Invasive mold infections following combat-related injuriesTyler Warkentien, Carlos Rodriguez, Bradley Lloyd, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2017
Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical SettingsIra M Lubin, Nazneen Aziz, Lawrence J Babb, et al.
Critical Care Medicine|May 18, 2022
A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With HyperinflammationBonnie E Lonze, Peter Spiegler, Russell N Wesson, et al.
Research Square|February 6, 2026
Intrinsic tumor factors and extrinsic environmental and social exposures contribute to endometrial cancer recurrence patternsJesus Gonzalez Bosquet, Oyomoare Osazuwa-Peters, Vincent M Wagner, et al.
Gynecologic Oncology|November 15, 2017
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancerCasey M Cosgrove, David L Tritchler, David E Cohn, et al.
American Journal of Veterinary Research|May 26, 2017
Characterization of aminoaciduria and hypoaminoacidemia in dogs with hepatocutaneous syndromeJohn P Loftus, Sharon A Center, John M Lucy, et al.
Nucleic Acids Research|October 23, 2020
Database resources of the National Center for Biotechnology InformationEric W Sayers, Jeffrey Beck, Evan E Bolton, et al.
Therapeutic Advances in Medical Oncology|September 30, 2024
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)Annika Auranen, Matthew A Powell, Vladyslav Sukhin, et al.
Molecular Cancer Therapeutics|August 28, 2020
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
Pageof 71